FLT3 and acute myeloid leukemia: A total of 83 patients with CN-AML, patients with WBC < 100,000/μL (p = 0.003) and wild-type FLT3-ITD (p < 0.001) were found to be significantly associated with increased RFS, while patients with WBC < 100,000/μL (p = 0.008) and patients aged < 60 years (p = 0.003) were associated with longer OS according to the univariate analysis.